Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$43.4 - $62.52 $918,908 - $1.32 Million
21,173 New
21,173 $936,000
Q1 2023

May 12, 2023

BUY
$36.57 - $58.29 $247,286 - $394,156
6,762 New
6,762 $375,000
Q1 2022

May 16, 2022

SELL
$30.32 - $91.33 $244,166 - $735,480
-8,053 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$86.26 - $119.0 $328,133 - $452,676
-3,804 Reduced 32.08%
8,053 $752,000
Q3 2021

Nov 12, 2021

SELL
$100.17 - $126.36 $28,648 - $36,138
-286 Reduced 2.36%
11,857 $1.32 Million
Q2 2021

Aug 16, 2021

SELL
$86.05 - $119.72 $324,236 - $451,104
-3,768 Reduced 23.68%
12,143 $1.38 Million
Q1 2021

May 12, 2021

BUY
$91.47 - $124.36 $756,639 - $1.03 Million
8,272 Added 108.29%
15,911 $1.62 Million
Q4 2020

Feb 12, 2021

SELL
$66.66 - $111.74 $816,051 - $1.37 Million
-12,242 Reduced 61.58%
7,639 $760,000
Q3 2020

Nov 12, 2020

SELL
$45.89 - $72.67 $180,072 - $285,157
-3,924 Reduced 16.48%
19,881 $1.44 Million
Q2 2020

Aug 13, 2020

BUY
$26.36 - $49.86 $42,755 - $80,872
1,622 Added 7.31%
23,805 $1.19 Million
Q1 2020

May 12, 2020

SELL
$17.27 - $40.17 $232,488 - $540,768
-13,462 Reduced 37.77%
22,183 $662,000
Q4 2019

Feb 11, 2020

BUY
$32.1 - $40.4 $279,077 - $351,237
8,694 Added 32.26%
35,645 $1.2 Million
Q3 2019

Nov 12, 2019

BUY
$25.38 - $34.89 $684,016 - $940,320
26,951 New
26,951 $884,000
Q1 2019

May 15, 2019

SELL
$11.34 - $20.62 $387,805 - $705,162
-34,198 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$12.32 - $24.38 $470,254 - $930,584
-38,170 Reduced 52.74%
34,198 $477,000
Q3 2018

Nov 13, 2018

SELL
$18.82 - $28.96 $125,849 - $193,655
-6,687 Reduced 8.46%
72,368 $1.73 Million
Q2 2018

Aug 14, 2018

BUY
$8.79 - $19.98 $694,893 - $1.58 Million
79,055 New
79,055 $1.49 Million
Q1 2018

May 15, 2018

SELL
$9.0 - $11.95 $491,076 - $652,039
-54,564 Closed
0 $0
Q4 2017

Feb 08, 2018

SELL
$8.99 - $14.31 $337,511 - $537,240
-37,543 Reduced 40.76%
54,564 $491,000
Q3 2017

Nov 14, 2017

BUY
$8.02 - $13.33 $738,698 - $1.23 Million
92,107
92,107 $1.19 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Advisory Research Inc Portfolio

Follow Advisory Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Research Inc with notifications on news.